The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy

AIDS. 1999 Oct 22;13(15):2188-9. doi: 10.1097/00002030-199910220-00035.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Body Composition
  • Drug Therapy, Combination
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Lipodystrophy / chemically induced*
  • Lipodystrophy / metabolism
  • Lipodystrophy / pathology
  • Male
  • Prospective Studies
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Stavudine / adverse effects*
  • Stavudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Stavudine